ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AHR vs V // EV/EBITDA & P/E VALUATION

American Healthcare REIT Inc. (NYSE) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: AHR 3 — V 8
▲ EV/EBITDA & P/E VALUATION LEADER: AHR
valuation
28.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHR VS. V) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AHR V SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 8.10% 32.30% -24.20 V /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 26.4x 28.9x -2.50 AHR /valuation <GO>
Free Cash Flow Yield 1.62% 2.90% -1.28 V /fcf-yield <GO>
Operating Margin 19.80% 60.00% -40.20 V /operating-margins <GO>
Net Profit Margin 3.40% 50.10% -46.70 V /net-margins <GO>
Revenue Growth (YoY) 11.20% 11.30% -0.10 V /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 1.32% 0.63% +0.69 AHR /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 9.09 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 9/9 -1.00 V /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.8 74.2 -18.40 V /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.11 1.06 +0.05 AHR /macro-sensitivity <GO>
Forward P/E Multiple — 34.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.54B $760.28B -$747.74B V /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AHR REV V REV AHR GROSS % V GROSS % AHR FCF V FCF
FY 2025 $2.09B $40.00B — — $200.2M $21.26B
FY 2024 $1.88B $35.93B — — $91.3M $18.33B
FY 2023 $1.67B $32.65B — — $23.4M $19.29B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHR // BETA 1.11
V // BETA 1.06